Retatrutide caused stomach trouble and raised the pulse
Sickness can make losing weight feel less welcome. People trying research products tell their own accounts. Medical studies offer stronger evidence about harm.
Relief from hunger came alongside sickness
A queasy stomach after a shot can disrupt your whole day. Retatrutide had no approval for a prescription anywhere as of 2026. People trying products marked for research have described feeling less hungry. Many also describe sickness, especially near the start.
Phase 2 means early studies that check benefit and harm. Those Phase 2 studies couldn't settle your risks over years of treatment. Doctors found faster pulses in people receiving more of the drug. The longer checks on hearts and kidneys haven't finished.
People trying research products describe unproved effects
People describing their own use of research products provide the accounts below. People trying retatrutide for research say these things happened; studies comparing treatments fairly haven't tested or confirmed these personal claims. A medical study checks groups receiving different treatments and watches everyone for harm. A personal account doesn't give you those checks or show what caused a problem.
Food occupied less of people's attention
The urge to eat often faded. People describe spending less time thinking about their next meal. Some say hunger nearly vanished, rather than saying they felt very full. Those are descriptions of how someone felt, without a study's hunger checks. Your appetite can't be predicted from another person's account.
Some reported a quick fall in weight. Their comparisons with similar medicines came from personal experience. Nobody gave both medicines the same fair test in these accounts. People sometimes noticed losses within the first few weeks. Separately, Phase 2, an early medical test, found about 24% weight loss at 12 mg over 48 weeks [1].
Some accounts linked less worry about food with better moods
Eating felt less troubling to some people. The accounts don't prove what caused a better mood. People suggested GLP-1, a hormone that helps control appetite, changed their thoughts about eating. They sometimes described feeling happier when food occupied less of their attention. That doesn't establish a mood benefit for you.
Feeling sick was a frequent complaint after shots
Nausea often began within hours. Nausea means feeling that you might vomit. Some people described the 4-8 hours after a shot as the worst. Their sickness sometimes eased after the start or an increase in amount. In Phase 2, up to 45% felt sick at the highest amount [1].
Pulse, warmth and bowel trouble also came up
A quicker heartbeat caught some people's attention. Some watches showed 5-15 extra beats per minute while people rested. That means sitting quietly, without exercise making the heart beat faster. The accounts can't show why each person's pulse rose. Phase 2 also found greater pulse rises with higher amounts [1].
Some skin felt warmer or looked flushed. People wondered whether glucagon, a hormone affecting energy use, caused the warmth. They hadn't tested that explanation in a medical study. Warm skin alone doesn't measure how much fat your body is burning. The warmth therefore can't establish a weight-loss benefit.
Burps sometimes had a rotten-egg smell. People suggested GLP-1 was involved because that hormone delays the passage of food out of the stomach. Others described the smell fading after a while. Those accounts don't show which explanation is right. They can't establish why your burps might change.
Tiredness sometimes followed a shot. People described heavy legs, more sleep and a drained feeling during the first weeks. Some thought eating much less explained the tiredness. Their accounts can't prove that cause, even when the tiredness began soon after hunger faded and they started eating smaller meals. Your new tiredness may need an explanation beyond another person's guess.
Constipation meant fewer or harder stools. People described passing stools less often than they normally did. Some blamed slower digestion or eating less food. Those possible causes weren't checked in a trial of these accounts. Those accounts can't explain the cause of your constipation.
Other accounts described itchy skin or broken sleep
Some shots left a small red or itchy patch. People often said the patch faded within 24-48 hours. Phase 2 found trouble around the shot site in about 8% [1]. That finding supports concern about skin trouble, without confirming every account. Your skin may react differently.
Some people kept waking or couldn't fall asleep. People wondered whether altered eating times or energy use disturbed sleep. Their accounts didn't test either possible cause. Another person's broken sleep can't explain your own sleep trouble. The reports raise a question that medical studies haven't settled.
A softer body prompted worries about losing muscle
The lost weight wasn't all body fat. People trying research products sometimes described feeling softer after rapid weight loss. A smaller 2025 study in type 2 diabetes found reductions in fat alongside loss of muscle and other tissue [12]. People discussed strength exercise and food protein, a substance your body uses to build and repair tissue. Those discussions haven't proved that either habit protects your strength during retatrutide use.
Retatrutide side effects may matter beyond your stomach
The Phase 2 studies were too short to settle harm over years. Their findings and drug-agency warnings provide the evidence for these cautions. The bracketed numbers lead you to the reports behind each claim. A product with unchecked contents brings extra risks beyond the trial findings.
An unchecked bottle's contents may not match its label. Retatrutide lacked FDA approval while Phase 3, the larger studies before possible approval, continued in mid-2026. Tests of similar research products found damaged medicine, altered ingredients or a different substance, and harmful germs or bacterial poisons in an unchecked shot can make you seriously ill. More than 50 FDA letters warned sellers offering retatrutide in 2025 [1][2].
Stomach and bowel trouble became worse with higher amounts. In Phase 2, nausea, vomiting, diarrhea and constipation were the main reasons people stopped. Sickness affected up to 45% at the highest amount; 18% stopped. By copying GLP-1, a hunger hormone, the drug delays food passing out of your stomach. Study doctors watched each person's response when amounts increased; those checks aren't part of an unknown bottle [1][2].
A faster pulse still needs checks for lasting harm. The highest Phase 2 amounts added about 5-7 beats per minute on average. The pulse rise was largest around 24 weeks. Glucagon, a hormone retatrutide copies, can speed up the heartbeat [1]. The longer heart study has no reported results, leaving your lasting heart risk uncertain [8].
Diabetes medicines can make very low sugar more likely. GLP-1 and GIP help release insulin, which helps your cells draw sugar from blood for fuel. Insulin shots or pills that increase insulin can bring sugar down too far. Doctors reduced insulin for people taking that treatment before joining the Phase 2 diabetes study. Doctors tested their sugar while adjusting treatment; those changes aren't instructions for your own care [2].
Losing weight also meant losing some muscle. The 2025 Lancet Diabetes and Endocrinology study examined adults who had type 2 diabetes [12]. Scans found less fat, but also less muscle and other tissue. The weight loss didn't consist of fat alone, and losing muscle matters for your strength in everyday life, especially when age or illness has already left you weaker.
The benefit after stopping hasn't been established. Retatrutide studies haven't yet shown whether weight stays down once treatment stops. Phase 2 studies of similar GLP-1 medicines found substantial weight returning after people stopped. That raises a concern without establishing that your weight would return as theirs did. A kidney-safety study follows more people to look for lasting harm [8].